EN | UA
EN | UA

Help Support

Back

Real-world study assesses evolution of Bisacodyl prescriptions in people with constipation

Bisacodyl prescriptions Bisacodyl prescriptions
Bisacodyl prescriptions Bisacodyl prescriptions

What's new?

For constipation management, Bisacodyl can be given at a stable dosage when used for >28 days in real-world clinical practice.

As per the findings of a retrospective, population-based, observational cohort real-world study, Bisacodyl can be administered at a stable dosage for more than twenty-eight days as most constipation sufferers stayed on their initial dosage during the follow-up. Also, there were no signs suggestive of habituation. The long-term use of Bisacodyl in constipation patients may raise safety issues related to potential habituation.

Michel Bouchoucha et al. sought to assess whether individuals with constipation who need Bisacodyl for a prolonged period of time will remain on a stable dose when treated for ≥ 28 days. From the Health Improvement Network French database, electronic medical record data of adults having constipation were gathered. The total amount of Bisacodyl exposure over the long term (≥28 days) and follow-up period (12 months) was assessed.  The key outcome ascertained was Bisacodyl's dosage alteration status during the follow-up from the initial dosage in the long-term cohort.

A total of 218 patients of the database's 5725 Bisacodyl users met the requirements to be included in the long-term cohort. Bisacodyl was commenced at doses of 5, 7.5, and 10 mg for a total of 166 (76.1%), 37 (17%), and 15 (6.9%) patients respectively. The majority (94%) of the participants continued taking their medication at the same dose they had been given for the first year during the follow-up. Only 6 people (2.8%) lowered their dose (2 from the 10 mg group and 4 from the 7.5 mg group), while 7 people (3.2%) had their dose elevated (from the initial prescription dose of 5 mg).

Source:

Drugs - Real World Outcomes

Article:

A Retrospective Real-World Observational Study Assessing the Evolution of Bisacodyl Prescriptions in Patients with Constipation During Long-Term Treatment

Authors:

Michel Bouchoucha et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: